Aziz Mottiwala Insider Profile
4 Followers
Aziz Mottiwala, President and CEO, Director at RxSight, holds ― shares in RxSight (Ticker: RXST), holds 61.48K shares in Tarsus Pharmaceuticals (Ticker: TARS). Most recently, Aziz Mottiwala ― shares of RxSight on ― for an estimated value of ―.
Aziz Mottiwala RxSight (RXST)President and CEO, Director
RxSight (RXST)
President and CEO, Director
Ranked #105,094 out of 108,921 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-100.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Aziz Mottiwala holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 20, 2025 - Mar 20, 2026
Return:-29.20%
The most profitable trade made by Aziz Mottiwala
Aziz Mottiwala's Trading History
RxSight
―
President and CEO, Director
―
―
Tarsus Pharmaceuticals
Mar 19, 2026
CCO
Informative Sell
892.53K
$5.09M
List of latest transactions for each holding click on a transaction to see Aziz Mottiwala's performance on stock
You May Also Like
Aziz Mottiwala insider profile FAQ
What is the percentage of profitable transactions made by Aziz Mottiwala?
The percentage of profitable transactions made by Aziz Mottiwala is 0%.
What is the average return per transaction made by Aziz Mottiwala?
The average return per transaction made by Aziz Mottiwala is -100.70%.
What stocks does Aziz Mottiwala hold?
Aziz Mottiwala holds: RXST, TARS stocks.
What was Aziz Mottiwala’s latest transaction?
Aziz Mottiwala latest transaction was an Uninformative Buy of ―.
What was Aziz Mottiwala's most profitable transaction?
Aziz Mottiwala’s most profitable transaction was an Informative Sell of TARS stock on March 20, 2025. The return on the trade was -29.20%.
What is Aziz Mottiwala's role in RxSight?
Aziz Mottiwala's role in RxSight is President and CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.